Fuzzy optimization for identifying anti-cancer targets with few side effects in constraint-based models of head and

Feng-Sheng Wang1, Pei-Rong Chen1, Ting-Yu Chen1

  • 1Department of Chemical Engineering, National Chung Cheng University, Chiayi, Taiwan.

Insights

This study introduces a novel fuzzy optimization method to identify anti-cancer drug targets for head and neck cancer (HNC). The approach minimizes side effects while maximizing cancer cell death, identifying promising targets for drug repurposing.

Area of Science:

  • Oncology
  • Computational Biology
  • Pharmacology

Background:

  • Computer-aided drug discovery often uses synthetic lethality but overlooks treatment side effects.
  • Identifying effective anti-cancer targets requires balancing efficacy with safety profiles.

Purpose of the Study:

  • To develop a fuzzy multi-objective optimization method for identifying anti-cancer targets.
  • To evaluate cancer cell mortality and minimize treatment-related side effects for head and neck cancer (HNC).

Main Methods:

  • Utilized fuzzy multi-objective optimization to screen potential anti-cancer enzymes and antimetabolites.
  • Focused on pathways including purine/pyrimidine metabolism and the pentose phosphate pathway.
  • Investigated single and dual-target enzyme combinations, including HMGCR, UMPS, and CAD.

Main Results:

  • Identified key enzymes and antimetabolites involved in critical cancer metabolic pathways.
  • Found that most identified targets are druggable with existing medications, suggesting drug repurposing potential for HNC.
  • Demonstrated that dual-target combinations (UMPS, HMGCR) and (CAD, HMGCR) significantly improved metabolic deviation and induced cell mortality without compromising cell viability.

Conclusions:

  • The developed fuzzy optimization approach effectively identifies anti-cancer targets by considering both efficacy and safety.
  • Identified specific enzyme targets and antimetabolites for HNC treatment, with potential for drug repurposing.
  • Dual-target strategies show promise for enhanced therapeutic outcomes in HNC by improving metabolic control and reducing viability.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.7K